Chicos FAS Inc (CHS) Stock Fundamental Analysis
NYSE:CHS - New York Stock Exchange, Inc. - US1686151028 - Common Stock - Currency: USD
We assign a fundamental rating of 5 out of 10 to CHS. CHS was compared to 120 industry peers in the Specialty Retail industry. Both the profitability and the financial health of CHS get a neutral evaluation. Nothing too spectacular is happening here. CHS has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year CHS was profitable.
In the past year CHS had a positive cash flow from operations.
In multiple years CHS reported negative net income over the last 5 years.
CHS had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
With a decent Return On Assets value of 8.82%, CHS is doing good in the industry, outperforming 79.84% of the companies in the same industry.
With a decent Return On Equity value of 26.40%, CHS is doing good in the industry, outperforming 79.84% of the companies in the same industry.
CHS's Return On Invested Capital of 12.31% is fine compared to the rest of the industry. CHS outperforms 77.52% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.82% | ||
| ROE | 26.4% | ||
| ROIC | 12.31% |
ROA(3y)-5.09%
ROA(5y)-2.53%
ROE(3y)-55.05%
ROE(5y)-32.32%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin of CHS (5.29%) is better than 72.87% of its industry peers.
CHS's Profit Margin has improved in the last couple of years.
The Operating Margin of CHS (6.16%) is better than 68.22% of its industry peers.
In the last couple of years the Operating Margin of CHS has grown nicely.
CHS has a Gross Margin (38.94%) which is in line with its industry peers.
In the last couple of years the Gross Margin of CHS has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.16% | ||
| PM (TTM) | 5.29% | ||
| GM | 38.94% |
OM growth 3YN/A
OM growth 5Y1.58%
PM growth 3YN/A
PM growth 5Y3.25%
GM growth 3Y4.35%
GM growth 5Y0.65%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CHS is creating some value.
The number of shares outstanding for CHS has been increased compared to 1 year ago.
Compared to 5 years ago, CHS has less shares outstanding
The debt/assets ratio for CHS has been reduced compared to a year ago.
2.2 Solvency
CHS has an Altman-Z score of 3.22. This indicates that CHS is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.22, CHS is doing good in the industry, outperforming 70.54% of the companies in the same industry.
The Debt to FCF ratio of CHS is 0.42, which is an excellent value as it means it would take CHS, only 0.42 years of fcf income to pay off all of its debts.
CHS has a better Debt to FCF ratio (0.42) than 82.17% of its industry peers.
A Debt/Equity ratio of 0.06 indicates that CHS is not too dependend on debt financing.
CHS has a Debt to Equity ratio of 0.06. This is in the better half of the industry: CHS outperforms 75.97% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 0.42 | ||
| Altman-Z | 3.22 |
ROIC/WACC1.34
WACC9.19%
2.3 Liquidity
CHS has a Current Ratio of 1.20. This is a normal value and indicates that CHS is financially healthy and should not expect problems in meeting its short term obligations.
CHS has a Current ratio of 1.20. This is in the lower half of the industry: CHS underperforms 72.09% of its industry peers.
CHS has a Quick Ratio of 1.20. This is a bad value and indicates that CHS is not financially healthy enough and could expect problems in meeting its short term obligations.
CHS's Quick ratio of 0.42 is on the low side compared to the rest of the industry. CHS is outperformed by 60.47% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.2 | ||
| Quick Ratio | 0.42 |
3. Growth
3.1 Past
The earnings per share for CHS have decreased strongly by -15.38% in the last year.
Measured over the past 5 years, CHS shows a small growth in Earnings Per Share. The EPS has been growing by 4.10% on average per year.
The Revenue has decreased by -0.24% in the past year.
The Revenue has been decreasing by -1.26% on average over the past years.
EPS 1Y (TTM)-15.38%
EPS 3YN/A
EPS 5Y4.1%
EPS Q2Q%-45%
Revenue 1Y (TTM)-0.24%
Revenue growth 3Y1.67%
Revenue growth 5Y-1.26%
Sales Q2Q%-2.54%
3.2 Future
The Earnings Per Share is expected to decrease by -8.47% on average over the next years.
CHS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.60% yearly.
EPS Next Y-18.51%
EPS Next 2Y-8.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.79%
Revenue Next 2Y0.6%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 9.86 indicates a reasonable valuation of CHS.
Compared to the rest of the industry, the Price/Earnings ratio of CHS indicates a somewhat cheap valuation: CHS is cheaper than 79.07% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.52, CHS is valued rather cheaply.
CHS is valuated reasonably with a Price/Forward Earnings ratio of 10.29.
CHS's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CHS is cheaper than 74.42% of the companies in the same industry.
CHS is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.25, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.86 | ||
| Fwd PE | 10.29 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CHS indicates a rather cheap valuation: CHS is cheaper than 85.27% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, CHS is valued a bit cheaper than the industry average as 67.44% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.37 | ||
| EV/EBITDA | 4.72 |
4.3 Compensation for Growth
The decent profitability rating of CHS may justify a higher PE ratio.
CHS's earnings are expected to decrease with -8.47% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)2.41
EPS Next 2Y-8.47%
EPS Next 3YN/A
5. Dividend
5.1 Amount
CHS does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
7.59
-0.01 (-0.13%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)
Earnings (Next)
Inst Owners0.13%
Inst Owner Change0%
Ins Owners3.85%
Ins Owner Change0%
Market Cap937.06M
Analysts46.67
Price Target7.75 (2.11%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.66%
Min EPS beat(2)2.68%
Max EPS beat(2)14.64%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.59%
Min Revenue beat(2)-2.73%
Max Revenue beat(2)-2.44%
Revenue beat(4)1
Avg Revenue beat(4)-1.54%
Min Revenue beat(4)-2.73%
Max Revenue beat(4)1.35%
Revenue beat(8)4
Avg Revenue beat(8)0.55%
Revenue beat(12)7
Avg Revenue beat(12)2.48%
Revenue beat(16)7
Avg Revenue beat(16)-0.31%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.23%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.86 | ||
| Fwd PE | 10.29 | ||
| P/S | 0.44 | ||
| P/FCF | 16.37 | ||
| P/OCF | 8.25 | ||
| P/B | 2.22 | ||
| P/tB | 2.34 | ||
| EV/EBITDA | 4.72 |
EPS(TTM)0.77
EY10.14%
EPS(NY)0.74
Fwd EY9.71%
FCF(TTM)0.46
FCFY6.11%
OCF(TTM)0.92
OCFY12.11%
SpS17.08
BVpS3.42
TBVpS3.25
PEG (NY)N/A
PEG (5Y)2.41
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.82% | ||
| ROE | 26.4% | ||
| ROCE | 15.79% | ||
| ROIC | 12.31% | ||
| ROICexc | 14.55% | ||
| ROICexgc | 15.01% | ||
| OM | 6.16% | ||
| PM (TTM) | 5.29% | ||
| GM | 38.94% | ||
| FCFM | 2.71% |
ROA(3y)-5.09%
ROA(5y)-2.53%
ROE(3y)-55.05%
ROE(5y)-32.32%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-2.56%
ROICexc growth 3YN/A
ROICexc growth 5Y1.76%
OM growth 3YN/A
OM growth 5Y1.58%
PM growth 3YN/A
PM growth 5Y3.25%
GM growth 3Y4.35%
GM growth 5Y0.65%
F-Score5
Asset Turnover1.67
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 0.42 | ||
| Debt/EBITDA | 0.14 | ||
| Cap/Depr | 134.65% | ||
| Cap/Sales | 2.67% | ||
| Interest Coverage | 35.98 | ||
| Cash Conversion | 66.14% | ||
| Profit Quality | 51.32% | ||
| Current Ratio | 1.2 | ||
| Quick Ratio | 0.42 | ||
| Altman-Z | 3.22 |
F-Score5
WACC9.19%
ROIC/WACC1.34
Cap/Depr(3y)46.44%
Cap/Depr(5y)47.4%
Cap/Sales(3y)1.18%
Cap/Sales(5y)1.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-15.38%
EPS 3YN/A
EPS 5Y4.1%
EPS Q2Q%-45%
EPS Next Y-18.51%
EPS Next 2Y-8.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.24%
Revenue growth 3Y1.67%
Revenue growth 5Y-1.26%
Sales Q2Q%-2.54%
Revenue Next Year0.79%
Revenue Next 2Y0.6%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-15.35%
EBIT growth 3YN/A
EBIT growth 5Y0.3%
EBIT Next Year18.25%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y29.25%
FCF growth 3YN/A
FCF growth 5Y0.2%
OCF growth 1Y108.67%
OCF growth 3Y69.3%
OCF growth 5Y-0.64%